


Healthcare News Roundup: Oncology
HSMN NewsFeed - 21 Apr 2014
EDAP Announces Reimbursement of HIFU Treatment for Prostate Cancer by France's Ministry of Health
EDAP Announces Reimbursement of HIFU Treatment for Prostate Cancer by France's Ministry of Health
HSMN NewsFeed - 21 Apr 2014
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
HSMN NewsFeed - 21 Apr 2014
OncoSec Medical Appoints Jean S. Campbell, Ph.D. as Executive Director of Research and Development
OncoSec Medical Appoints Jean S. Campbell, Ph.D. as Executive Director of Research and Development
HSMN NewsFeed - 8 Apr 2014
Epic Sciences Appoints Pascal Bamford, Ph.D. as Vice President of Product Development
Epic Sciences Appoints Pascal Bamford, Ph.D. as Vice President of Product Development
HSMN NewsFeed - 3 Apr 2014
EMBL Ventures Invests £2M ($3.3M) in a Second Close of Crescendo Biologics' Series A Financing
EMBL Ventures Invests £2M ($3.3M) in a Second Close of Crescendo Biologics' Series A Financing
HSMN NewsFeed - 2 Apr 2014
First Austrian cancer patients receive treatments on advanced Elekta Versa HD radiation therapy system
First Austrian cancer patients receive treatments on advanced Elekta Versa HD radiation therapy system
HSMN NewsFeed - 1 Apr 2014
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
HSMN NewsFeed - 31 Mar 2014
New Global Initiative Aims to Improve Patient Outcomes in Metastatic Colorectal Cancer
New Global Initiative Aims to Improve Patient Outcomes in Metastatic Colorectal Cancer
HSMN NewsFeed - 27 Mar 2014
Accuray Incorporated's CyberKnife(R) M6(TM) System Receives Shonin Approval
Accuray Incorporated's CyberKnife(R) M6(TM) System Receives Shonin Approval
HSMN NewsFeed - 26 Mar 2014
Bio-Path Holdings, Inc. Appoints Ulrich W. Mueller Chief Operating Officer
Bio-Path Holdings, Inc. Appoints Ulrich W. Mueller Chief Operating Officer
HSMN NewsFeed - 25 Mar 2014
Calithera Biosciences Appoints William D. Waddill Chief Financial Officer
Calithera Biosciences Appoints William D. Waddill Chief Financial Officer
HSMN NewsFeed - 19 Mar 2014
IsoRay Announces World's First Pediatric Cesium-131 Seeded Mesh Treatment for Metastatic Wilms Tumor
IsoRay Announces World's First Pediatric Cesium-131 Seeded Mesh Treatment for Metastatic Wilms Tumor
HSMN NewsFeed - 19 Mar 2014
RaySearch Secures Distribution of Raystation(R) in Australia and New Zealand
RaySearch Secures Distribution of Raystation(R) in Australia and New Zealand
HSMN NewsFeed - 18 Mar 2014
NeoGenomics Announces Next Generation Sequencing Tests for Solid Tumor Cancers and Myelodysplastic Syndrome
NeoGenomics Announces Next Generation Sequencing Tests for Solid Tumor Cancers and Myelodysplastic Syndrome
HSMN NewsFeed - 5 Mar 2014
Leading Cancer Center in Portugal Becomes First in World to Offer Edge(TM) Radiosurgery
Leading Cancer Center in Portugal Becomes First in World to Offer Edge(TM) Radiosurgery
HSMN NewsFeed - 5 Mar 2014
Genmab Announces Phase III Study of Daratumumab in Relapsed or Refractory Multiple Myeloma
Genmab Announces Phase III Study of Daratumumab in Relapsed or Refractory Multiple Myeloma
HSMN NewsFeed - 4 Mar 2014
Atossa Genetics Inc. Announces FDA Response to 510(k) Submission for ForeCYTE Breast Aspirator
Atossa Genetics Inc. Announces FDA Response to 510(k) Submission for ForeCYTE Breast Aspirator
HSMN NewsFeed - 3 Mar 2014
Genentech Provides Update on Phase III Study of Onartuzumab in People with Specific Type of Lung Cancer
Genentech Provides Update on Phase III Study of Onartuzumab in People with Specific Type of Lung Cancer
